Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UNUSUAL PRESENTATIONS OF LMNA-ASSOCIATED LIPODYSTROPHY WITH COMPLEX PHENOTYPES AND GENERALIZED FAT LOSS: WHEN THE GENETIC DIAGNOSIS UNCOVERS NOVEL FEATURES.
de Andrade NXS, Adiyaman SC, Yuksel BD, Ferrari CT, Eldin AJ, Saydam BO, Altay C, Sharma P, Bhave N, Little A, McKeever P, Onay H, Ozkal S, Secil M, Yenerel MN, Akinci B, Oral EA. de Andrade NXS, et al. Among authors: oral ea. AACE Clin Case Rep. 2020 Mar 4;6(2):e79-e85. doi: 10.4158/ACCR-2019-0366. eCollection 2020 Mar-Apr. AACE Clin Case Rep. 2020. PMID: 32524016 Free PMC article.
Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy.
Akinci B, Onay H, Demir T, Savas-Erdeve Ş, Gen R, Simsir IY, Keskin FE, Erturk MS, Uzum AK, Yaylali GF, Ozdemir NK, Atik T, Ozen S, Yurekli BS, Apaydin T, Altay C, Akinci G, Demir L, Comlekci A, Secil M, Oral EA. Akinci B, et al. Among authors: oral ea. Metabolism. 2017 Jul;72:109-119. doi: 10.1016/j.metabol.2017.04.010. Epub 2017 Apr 27. Metabolism. 2017. PMID: 28641778
Renal complications of lipodystrophy: A closer look at the natural history of kidney disease.
Akinci B, Unlu SM, Celik A, Simsir IY, Sen S, Nur B, Keskin FE, Ozgen Saydam B, Kutbay Ozdemir N, Sarer Yurekli B, Ergur BU, Sonmez M, Atik T, Arslan A, Demir T, Altay C, Tunc UA, Arkan T, Gen R, Eren E, Akinci G, Yilmaz AA, Bilen H, Ozen S, Celtik A, Savas Erdeve S, Cetinkaya S, Onay H, Sarioglu S, Oral EA. Akinci B, et al. Among authors: oral ea. Clin Endocrinol (Oxf). 2018 Jul;89(1):65-75. doi: 10.1111/cen.13732. Epub 2018 May 17. Clin Endocrinol (Oxf). 2018. PMID: 29722904 Free PMC article.
Update on Therapeutic Options in Lipodystrophy.
Akinci B, Meral R, Oral EA. Akinci B, et al. Among authors: oral ea. Curr Diab Rep. 2018 Oct 29;18(12):139. doi: 10.1007/s11892-018-1100-7. Curr Diab Rep. 2018. PMID: 30370487 Review.
The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide.
Akinci B, Meral R, Rus D, Hench R, Neidert AH, DiPaola F, Westerhoff M, Taylor SI, Oral EA. Akinci B, et al. Among authors: oral ea. Endocrinol Diabetes Metab Case Rep. 2020 Mar 25;2020:19-0139. doi: 10.1530/EDM-19-0139. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2020. PMID: 32213649 Free PMC article.
Diagnostic strategies and clinical management of lipodystrophy.
Foss-Freitas MC, Akinci B, Luo Y, Stratton A, Oral EA. Foss-Freitas MC, et al. Among authors: oral ea. Expert Rev Endocrinol Metab. 2020 Mar;15(2):95-114. doi: 10.1080/17446651.2020.1735360. Expert Rev Endocrinol Metab. 2020. PMID: 32368944 Review.
128 results